chr16-4340910-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016069.11(PAM16):c.291+10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00297 in 1,612,954 control chromosomes in the GnomAD database, including 131 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.015 ( 53 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 78 hom. )
Consequence
PAM16
NM_016069.11 intron
NM_016069.11 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.138
Publications
1 publications found
Genes affected
PAM16 (HGNC:29679): (presequence translocase associated motor 16) This gene encodes a mitochondrial protein involved in granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling. This protein also plays a role in the import of nuclear-encoded mitochondrial proteins into the mitochondrial matrix and may be important in reactive oxygen species (ROS) homeostasis. Mutations in this gene cause Megarbane-Dagher-Melike type spondylometaphyseal dysplasia, an early lethal skeletal dysplasia characterized by short stature, developmental delay and other skeletal abnormalities. [provided by RefSeq, May 2017]
CORO7-PAM16 (HGNC:44424): (CORO7-PAM16 readthrough) This locus represents naturally occurring read-through transcription between the neighboring CORO7 (coronin 7) and PAM16 (presequence translocase-associated motor 16) genes on chromosome 16. The read-through transcript encodes a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 16-4340910-G-A is Benign according to our data. Variant chr16-4340910-G-A is described in ClinVar as Benign. ClinVar VariationId is 783731.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0542 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PAM16 | NM_016069.11 | c.291+10C>T | intron_variant | Intron 4 of 4 | ENST00000318059.8 | NP_057153.8 | ||
| CORO7-PAM16 | NM_001201479.2 | c.3060+10C>T | intron_variant | Intron 30 of 30 | NP_001188408.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PAM16 | ENST00000318059.8 | c.291+10C>T | intron_variant | Intron 4 of 4 | 1 | NM_016069.11 | ENSP00000315693.3 | |||
| CORO7-PAM16 | ENST00000572467.5 | c.3060+10C>T | intron_variant | Intron 30 of 30 | 2 | ENSP00000460885.1 |
Frequencies
GnomAD3 genomes AF: 0.0149 AC: 2258AN: 152050Hom.: 53 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2258
AN:
152050
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00408 AC: 1025AN: 250948 AF XY: 0.00308 show subpopulations
GnomAD2 exomes
AF:
AC:
1025
AN:
250948
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00173 AC: 2526AN: 1460786Hom.: 78 Cov.: 32 AF XY: 0.00150 AC XY: 1090AN XY: 726648 show subpopulations
GnomAD4 exome
AF:
AC:
2526
AN:
1460786
Hom.:
Cov.:
32
AF XY:
AC XY:
1090
AN XY:
726648
show subpopulations
African (AFR)
AF:
AC:
1885
AN:
33460
American (AMR)
AF:
AC:
155
AN:
44538
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26134
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
12
AN:
86254
European-Finnish (FIN)
AF:
AC:
0
AN:
52816
Middle Eastern (MID)
AF:
AC:
21
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
227
AN:
1111746
Other (OTH)
AF:
AC:
226
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
124
248
371
495
619
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0149 AC: 2264AN: 152168Hom.: 53 Cov.: 33 AF XY: 0.0142 AC XY: 1054AN XY: 74416 show subpopulations
GnomAD4 genome
AF:
AC:
2264
AN:
152168
Hom.:
Cov.:
33
AF XY:
AC XY:
1054
AN XY:
74416
show subpopulations
African (AFR)
AF:
AC:
2149
AN:
41524
American (AMR)
AF:
AC:
60
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5174
South Asian (SAS)
AF:
AC:
3
AN:
4818
European-Finnish (FIN)
AF:
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
25
AN:
67978
Other (OTH)
AF:
AC:
26
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
113
226
340
453
566
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
18
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 04, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.